Roundhill Cannabis ETF

Cannabis Industry Overview

Cannabis exchange-traded funds (ETFs) provide investors with diversified exposure to the cannabis industry through a single security, eliminating the need to pick individual winners in a volatile and rapidly evolving market. These funds typically track purpose-built cannabis indexes and hold baskets of stocks spanning MSOs, licensed producers, ancillary companies, REITs, and biotechs. The diversification benefit is particularly valuable in cannabis, where single-stock risk is elevated due to regulatory uncertainty, early-stage business models, and liquidity constraints. Cannabis ETFs trade on major exchanges with standard settlement, making them accessible to a broad range of investors including those whose brokerage accounts restrict direct OTC trading. Key considerations for ETF investors include the expense ratio, the index methodology (market-cap-weighted vs. equal-weighted), geographic focus (US-only vs. global), and whether the fund holds US plant-touching operators or is limited to Canadian and ancillary names due to exchange listing rules. Trading volume and bid-ask spreads are also important, as some cannabis ETFs have limited liquidity.

Roundhill Cannabis ETF in the Cannabis ETF Landscape

Roundhill Cannabis ETF (WEED) currently ranks #6 out of 6 publicly traded cannabis etf companies by market capitalization, with a market cap of $9.0M. Revenue data is not currently available for this company. The cannabis etf sector comprises 6 tracked companies, reflecting the focused competitive landscape within this segment of the cannabis industry.

The top companies in the cannabis etf sector by market capitalization are AdvisorShares Pure US Cannabis ETF (MSOS) at $786.9M, ETFMG Alternative Harvest ETF (MJ) at $113.0M, and Amplify Seymour Cannabis ETF (CNBS) at $75.1M. Roundhill Cannabis ETF competes within this group for market share, investor attention, and operational scale as the sector continues to mature.

Key Metrics at a Glance

Regulatory & Risk Considerations

All cannabis investors should be aware that federal legalization status in the United States remains uncertain. While cannabis is legal for medical use in the majority of US states and for adult use in a growing number of jurisdictions, it remains classified as a Schedule I controlled substance at the federal level. This creates material legal, financial, and operational risks across the industry. Cannabis ETFs like Roundhill Cannabis ETF aggregate the risks of their underlying holdings, meaning investors are exposed to the full spectrum of cannabis industry risks through a single vehicle. ETF-specific risks include tracking error relative to the benchmark index, fund closure if assets under management fall below economically viable thresholds, and the impact of portfolio rebalancing on illiquid underlying stocks.

Many cannabis ETFs are restricted from holding US plant-touching operators due to exchange listing rules, which means their portfolios may skew toward Canadian LPs and ancillary companies. This creates a geographic and regulatory mismatch for investors seeking exposure to the largest cannabis market in the world — the United States. Investors should carefully review each ETF's prospectus and index methodology to understand exactly which segments of the cannabis market are represented.